Chronic Disease
·MeSH: Chronic Disease
Prevalence
201.0 / 100K
Incidence
6.0 / 100K/yr
7 drugs in development·6 companies·4 clinical trials
Drug Pipeline by Phase
Approved(5)
Phase 2(1)
| Drug | Company |
|---|---|
| azelaprag | BioAge Labs, Inc. (BIOA) |
Preclinical(1)
| Drug | Company |
|---|---|
| hpp3033 | vTv Therapeutics Inc. (VTVT) |
Compare drugs
Frequently asked questions
How many drugs are in development for Chronic Disease?
BioSniper tracks 7 drugs in development for Chronic Disease across 6 companies.
How many clinical trials target Chronic Disease?
There are 4 clinical trials targeting Chronic Disease tracked by BioSniper.
What is the prevalence of Chronic Disease?
The estimated prevalence of Chronic Disease is approximately 201.0 per 100,000 population.
Deep-dive into Chronic Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis